169 related articles for article (PubMed ID: 8142207)
41. Determinants of the transglomerular passage of macromolecules.
Deen WM; Bohrer MP; Robertson CR; Brenner BM
Fed Proc; 1977 Nov; 36(12):2614-8. PubMed ID: 913620
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
[TBL] [Abstract][Full Text] [Related]
43. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis.
Greive KA; Nikolic-Paterson DJ; Guimarães MA; Nikolovski J; Pratt LM; Mu W; Atkins RC; Comper WD
Am J Pathol; 2001 Sep; 159(3):1159-70. PubMed ID: 11549609
[TBL] [Abstract][Full Text] [Related]
44. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
45. Glomerulonephropathy of Laurence-Moon-Biedl syndrome.
Cheng IK; Chan KW; Chan MK; Kung A; Ma J; Wang C
Postgrad Med J; 1988 Aug; 64(754):621-5. PubMed ID: 3249710
[TBL] [Abstract][Full Text] [Related]
46. Renal selectivity properties towards endogenous albumin in minimal change nephropathy.
Ghiggeri GM; Candiano G; Ginevri F; Gusmano R; Ciardi MR; Perfumo F; Delfino G; Cuniberti C; Queirolo C
Kidney Int; 1987 Jul; 32(1):69-77. PubMed ID: 3306098
[TBL] [Abstract][Full Text] [Related]
47. Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes.
Jao W; Pollak VE; Norris SH; Lewy P; Pirani CL
Medicine (Baltimore); 1973 Sep; 52(5):445-68. PubMed ID: 4725964
[No Abstract] [Full Text] [Related]
48. Distribution of endogenous albumin in the glomerular wall of proteinuric patients.
Russo PA; Bendayan M
Am J Pathol; 1990 Dec; 137(6):1481-90. PubMed ID: 2260634
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
Myers BD; Winetz JA; Chui F; Michaels AS
Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
[TBL] [Abstract][Full Text] [Related]
50. Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuria.
Branten AJ; Wetzels JF
Nephron; 1999; 81(3):329-33. PubMed ID: 10050089
[TBL] [Abstract][Full Text] [Related]
51. Transport of molecules across renal glomerular capillaries.
Brenner BM; Baylis C; Deen WM
Physiol Rev; 1976 Jul; 56(3):502-34. PubMed ID: 778868
[TBL] [Abstract][Full Text] [Related]
52. [Minimal change nephrotic syndrome: Pathogenesis, pathophysiology and therapy].
Wakui H; Komatsuda A
Nihon Rinsho; 2006 Feb; 64 Suppl 2():408-12. PubMed ID: 16523923
[No Abstract] [Full Text] [Related]
53. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
54. Nature of the glomerular capillary injury in human membranous glomerulopathy.
Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
[TBL] [Abstract][Full Text] [Related]
55. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
56. Glomerular permselectivity in early stages of overt diabetic nephropathy.
Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
[TBL] [Abstract][Full Text] [Related]
57. [Physiologic and pathophysiologic fundamentals of proteinuria--a review].
Raila J; Forterre S; Schweigert FJ
Berl Munch Tierarztl Wochenschr; 2005; 118(5-6):229-39. PubMed ID: 15918488
[TBL] [Abstract][Full Text] [Related]
58. Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.
Kaneko K; Tsuji S; Kimata T; Kitao T; Yamanouchi S; Kato S
World J Pediatr; 2015 Feb; 11(1):21-8. PubMed ID: 25822700
[TBL] [Abstract][Full Text] [Related]
59. A quantitative immunofluorescence study of glomerular cell adhesion proteins in proteinuric states.
Bains R; Furness PN; Critchley DR
J Pathol; 1997 Nov; 183(3):272-80. PubMed ID: 9422981
[TBL] [Abstract][Full Text] [Related]
60. Renal function during recovery from minimal lesions nephrotic syndrome.
Koomans HA; Boer WH; Dorhout Mees EJ
Nephron; 1987; 47(3):173-8. PubMed ID: 3317090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
